Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection

Key Points

• Inhibition of in vitro growth of p. falciparum highlights licochalcone A's potential as an antimalarial agent.
• Key evidence shows that licochalcone A effectively protects mice from p. yoelii infection, underscoring its efficacy.
• Analysis of drug effects compared growth rates of treated versus untreated malaria parasites in laboratory settings.
• Supports ongoing efforts to explore plant-derived compounds for malaria treatments and further studies are needed.